Syncona logo

Syncona

Growth Equity

London, England, GB

Syncona is a healthcare company focused on founding, building, and funding life science businesses to deliver transformational treatments in areas of high unmet need. With a diversified portfolio of clinical and pre-clinical companies, Syncona leverages exceptional science and a long-term view to improve patient lives, create sustainable companies, and provide strong returns to shareholders. The company is publicly traded on the London Stock Exchange (LON: SYNC).

Recent Transactions involving Syncona

Deal Target Platform Buyer Industry

Syncona to Acquire Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation

Syncona

Gene Therapy

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →